DE602004022191D1 - Cc-chemokin-bindende zeckenproteine - Google Patents
Cc-chemokin-bindende zeckenproteineInfo
- Publication number
- DE602004022191D1 DE602004022191D1 DE602004022191T DE602004022191T DE602004022191D1 DE 602004022191 D1 DE602004022191 D1 DE 602004022191D1 DE 602004022191 T DE602004022191 T DE 602004022191T DE 602004022191 T DE602004022191 T DE 602004022191T DE 602004022191 D1 DE602004022191 D1 DE 602004022191D1
- Authority
- DE
- Germany
- Prior art keywords
- chemokin
- tick proteins
- binding
- binding tick
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010000241 Arthropod Proteins Proteins 0.000 title 1
- 102000001902 CC Chemokines Human genes 0.000 abstract 2
- 108010040471 CC Chemokines Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 241001481696 Rhipicephalus sanguineus Species 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 108091008324 binding proteins Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104973 | 2003-12-24 | ||
| PCT/EP2004/053638 WO2005063812A2 (en) | 2003-12-24 | 2004-12-21 | Cc-chemokine-binding tick proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004022191D1 true DE602004022191D1 (de) | 2009-09-03 |
Family
ID=34717258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004022191T Active DE602004022191D1 (de) | 2003-12-24 | 2004-12-21 | Cc-chemokin-bindende zeckenproteine |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7393660B2 (de) |
| EP (1) | EP1697404B1 (de) |
| JP (1) | JP4809242B2 (de) |
| AT (1) | ATE437179T1 (de) |
| AU (1) | AU2004309111B2 (de) |
| CA (1) | CA2544334A1 (de) |
| DE (1) | DE602004022191D1 (de) |
| ES (1) | ES2329584T3 (de) |
| IL (1) | IL176327A (de) |
| NO (1) | NO20063413L (de) |
| WO (1) | WO2005063812A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7670802B2 (en) * | 2005-10-31 | 2010-03-02 | Merck Serono Sa | CXC-chemokine antagonists isolated from Rhipicephalus sanguineus |
| GB0522298D0 (en) * | 2005-11-01 | 2005-12-07 | Natural Environment Res | Agents that bind IgE |
| CA2630928A1 (en) * | 2006-02-16 | 2007-08-23 | Laboratoires Serono S.A. | Novel cc-chemokine antagonists |
| WO2007148317A1 (en) * | 2006-06-21 | 2007-12-27 | Compugen Ltd. | Mcp-1 splice variants and methods of using same |
| CN107102142A (zh) | 2007-03-27 | 2017-08-29 | 伊缪诺维亚公司 | 检测腺癌的蛋白标志/标记 |
| GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849536A (en) * | 1990-03-02 | 1998-12-15 | Bio-Technology General Corp. | Cloning and production of human von willebrand factor GPIb binding domain polypeptides and methods of using same |
| WO2000027873A2 (en) * | 1998-11-06 | 2000-05-18 | Research Corporation Technologies, Inc. | Interleukin-2 binding protein from arthropods |
| AU2001232052A1 (en) | 2000-02-11 | 2001-08-20 | Evolutec Limited | Cytokine inhibitory molecules from tick salivary glands |
| WO2001078770A1 (en) * | 2000-04-14 | 2001-10-25 | The Regents Of The University Of California | Inhibition of transmission of tick-borne infections |
-
2004
- 2004-12-21 AU AU2004309111A patent/AU2004309111B2/en not_active Ceased
- 2004-12-21 JP JP2006546177A patent/JP4809242B2/ja not_active Expired - Fee Related
- 2004-12-21 WO PCT/EP2004/053638 patent/WO2005063812A2/en active Application Filing
- 2004-12-21 US US10/583,218 patent/US7393660B2/en not_active Expired - Fee Related
- 2004-12-21 DE DE602004022191T patent/DE602004022191D1/de active Active
- 2004-12-21 CA CA002544334A patent/CA2544334A1/en not_active Abandoned
- 2004-12-21 EP EP04804972A patent/EP1697404B1/de active Active
- 2004-12-21 AT AT04804972T patent/ATE437179T1/de not_active IP Right Cessation
- 2004-12-21 ES ES04804972T patent/ES2329584T3/es active Active
-
2006
- 2006-06-15 IL IL176327A patent/IL176327A/en not_active IP Right Cessation
- 2006-07-24 NO NO20063413A patent/NO20063413L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1697404B1 (de) | 2009-07-22 |
| IL176327A (en) | 2012-03-29 |
| WO2005063812A2 (en) | 2005-07-14 |
| US20070224125A1 (en) | 2007-09-27 |
| EP1697404A2 (de) | 2006-09-06 |
| CA2544334A1 (en) | 2005-07-14 |
| NO20063413L (no) | 2006-09-25 |
| JP2008505604A (ja) | 2008-02-28 |
| ES2329584T3 (es) | 2009-11-27 |
| JP4809242B2 (ja) | 2011-11-09 |
| IL176327A0 (en) | 2006-10-05 |
| AU2004309111B2 (en) | 2011-02-24 |
| WO2005063812A3 (en) | 2005-10-27 |
| AU2004309111A1 (en) | 2005-07-14 |
| US7393660B2 (en) | 2008-07-01 |
| ATE437179T1 (de) | 2009-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60325209D1 (de) | Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen | |
| EP2182006A3 (de) | Zusammensetzungen und Verfahren zur Behandlung von Immunerkrankungen | |
| WO2004039956A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
| DE602004022061D1 (de) | Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen | |
| DK1206474T3 (da) | Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer | |
| DE60329237D1 (de) | Kristalline form von linezolid | |
| EA200600588A1 (ru) | Соединения, содержащие галоидалкил, как ингибиторы цистеиновых протеаз | |
| BG66080B1 (bg) | Заместени тиоацетамиди | |
| NO20062694L (no) | Inhibitor av mutant form av KIT | |
| DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
| HUP0402396A2 (hu) | Aszkomicintartalmú, a szem kezelésére szolgáló készítmények | |
| IL176327A0 (en) | Cc-chemokine binding proteins, their preparation and their use | |
| DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| SE0203825D0 (sv) | Novel fused heterocycles and uses thereof | |
| DE60203299D1 (de) | Fungizide zusammensetzung und verwendung dieser zusammensetzung zur bekämpfung von pflanzenkrankheiten | |
| SE0302304D0 (sv) | Novel compounds | |
| ATE469886T1 (de) | 17beta-hydroxysteroid dehydrogenase typ-3 hemmer zur behandlung von androgen abhängigen erkrankungen | |
| DE60333205D1 (de) | Histaminika zur behandlung von allergischer rhinitis | |
| DE602004015504D1 (de) | Von injektionspräparaten | |
| ATE527280T1 (de) | Fluoreszentprotein und chromoprotein | |
| WO2004024077A3 (en) | Novel composition and methods for the treatment of psoriasis | |
| DE602004007564D1 (de) | Verwendung von mikrobioziden Zusammensetzungen enthaltend 2-Methyl-4-Isothiazolin-3-on | |
| ATE426613T1 (de) | Cc-chemokin-antagonisten | |
| MXPA04001986A (es) | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |